ACN Newswire

Wed Feb 12

AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen(R) for Use Against the SARS-like Wuhan 2019 Novel Coronavirus

Written by ACN Newswire

OCALA, FL / ACCESSWIRE, Feb 11, 2020 - (ACN Newswire) - AIM ImmunoTech Inc. (NYSE American:AIM) today announced the filing of three provisional patent applications related to its drug candidate Ampligen in the company's efforts toward joining the global health community in the fight against the deadly Wuhan coronavirus that has so far infected...

ACN Newswire

AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen(R) for Use Against the SARS-like Wuhan 2019 Novel Coronavirus

Cross-pollination, migration, adaptation: Australia's fragile grasslands at the Venice Biennale

Why a code of conduct may not be enough to change the boys' club culture in the Liberal Party

Smoking at record low in Australia, but the grim harvest of preventable heart disease continues

The Australian government needs to step up its fight to free Kylie Moore-Gilbert from prison in Iran

We need to talk about discrimination law and why a thoughtful approach to reform is so important

Explainer: the ideas of Foucault

There is still no US Ambassador to Australia, but it is neither an insult nor a concern

5 tips on how to be a good mentor to someone twice your age

In Rozanna Lilley's memoir, a curious life gets even more curious

In our time of climate crisis, the exhibition Water is a subtly crafted plea

What should buyers of a house be told about it?